Soluble Epoxide Hydrolase Inhibitors Reduce the Development of Atherosclerosis in Apolipoprotein E-Knockout Mouse Model
Journal of Cardiovascular Pharmacology - United States
doi 10.1097/fjc.0b013e318185fa3c
Full Text
Open PDFAbstract
Available in full text
Date
October 1, 2008
Authors
Publisher
Ovid Technologies (Wolters Kluwer Health)